Company intelligence / Profile preview

IdeeLab

Piracicaba, São Paulo, Brazil

Ownership: Private
Employees: ~37
Development stage: Other

Overview

IdeeLab is demonstrating proof-of-concept efficacy for peptide/protein/metabolite-based biocontrol strategies against citrus pathogens and is scaling production with a newly opened industrial facility; product prototypes are in the final development stage

Therapeutic areas: Infectious DiseasesMetabolic DisordersOther
Modalities: MicroorganismsMetabolitesRecombinant proteinPeptideRNAi-based productCRISPR-edited microorganism
Industry: Agriculture & AgTech

Partnerships

Ginkgo Bioworks (joined Ginkgo Technology Network for R&D and manufacturing integration)

Beyond the preview

Go deeper on IdeeLab.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IdeeLab.

Explore the full profile